Sage Journals: Discover world-class research

Abstract

This study examines the relationship between inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in the control of cervical ripening and parturition under normal (normal term pregnancy) and abnormal (preterm labor and prolongation of pregnancy) conditions by (a) measuring changes in the collagen both visually and quantitatively, (b) localizing and characterizing iNOS and COX-2 under normal conditions, and (c) characterizing the changes in iNOS and COX-2 under abnormal conditions. Cervices are obtained from estrus and timed pregnant Sprague-Dawley rats (n=4-10 per group). Preterm labor is induced with Onapristone (3 mg/rat; progesterone antagonist) and the prolongation of pregnancy with progesterone (2.5 mg, twice daily). Collagen changes are measured and visualized with the picrosirius polarization method. RT-PCR is used to characterize the mRNA expression (p<0.5), and immunohistochemistry is used to localize the protein expression for iNOS and COX-2. The organization and birefringence of the collagen during pregnancy decreased and is supported by changes in the luminosity (p<0.001). The iNOS and COX-2 enzymes were localized in cervical smooth muscle, vascular smooth muscle, and epithelium. Under normal conditions, iNOS mRNA levels decreased as COX-2 mRNA levels increased demonstrating an inverse correlation (Spearman r = −0.497; p=0.00295). Onapristone stimulated preterm labor, increasing the iNOS and COX-2 mRNA (p<0.05). The increase demonstrated a positive correlation (Spearman r = 0.456; p=0.03). Progesterone prolonged pregnancy, decreasing the iNOS and COX-2 mRNA (p=0.036). In conclusion, there may be an interaction between the nitric oxide and prostaglandin pathways in cervical ripening and parturition.

Keywords

iNOS COX-2 rat cervix progesterone Onapristone cervical ripening parturition nitric oxide prostaglandin

Cervical ripening (softening, effacement, and dilation) is a prerequisite for the normal progression of labor and requires the coordinated timing of biochemical and structural changes for a successful end to the pregnancy (Stys et al. 1978; Uldbjerg et al. 1983a,c; Calder and Greer 1992; Buhimschi et al. 1996; Dong et al. 1996; Ali et al. 1997; Shi et al. 1999). Changes occurring in the cervix during the ripening process initially were thought to be passive; however, it is now known that the ripening process is an active process with the consistency of the cervix progressively changing (Danforth et al. 1974; Ito et al. 1979; Forman et al. 1982a,b; Conrad and Ueland 1983; Uldbjerg et al. 1983a-c; Leppert 1992; Leppert and Yu 1994). The mechanisms and mediators that control cervical ripening and parturition are still largely unknown even though nitric oxide (NO) and prostaglandins (PGs) have been shown to be involved in the ripening cascade and parturition (Stys et al. 1981; Szalay et al. 1981; Ekman et al. 1983a-c,e; Calder and Greer 1992; Calder 1994; Buhimschi et al. 1996; Dong et al. 1996; Ali et al. 1997; Chwalisz et al. 1997; Thomson et al. 1997; Ledingham et al. 2000).

Treatment with NO donors, such as isosorbide-mononitrate and glyceryl-trinitrate in humans, stimulate the ripening process (Thomson et al. 1997; Norman et al. 1998; Thomson et al. 1998). Inducible nitric oxide synthase (iNOS) is present in the cervix of many different species during pregnancy and increases during labor, suggesting a role for NO in the ripening process and parturition (Nathan 1992; Gilbert and Herschman 1993a,b; Kitajima et al. 1994; Vane et al. 1994; Buhimschi et al. 1996; Ali et al. 1997; Ledingham et al. 2000). Local applications of NO in animals and humans produce characteristics associated with the ripening process (Chwalisz et al. 1997; Thomson et al. 1997; Thomson et al. 1998; Shi et al. 2000b). N-nitro-L-arginine methyl ester, a nonspecific NOS inhibitor, prolongs time cervical dilation and decreases cervical extensibility. N-nitro-L-arginine methyl ester also prolongs delivery (Buhimschi et al. 1996; Shi et al. 2000b). These studies would suggest that NO plays an important role in the ripening of the cervix and parturition.

PGs are used to interrupt pregnancy in humans in the second trimester and also to stimulate cervical ripening at term (Szalay et al. 1981; Theobald et al. 1982; Ekman et al. 1983a,b,d,e; Calder and Greer 1992; Calder, 1994). Cyclooxygenase-2 (COX-2) is found in the cervix and sharply increases during labor or just before labor (Calder et al. 1977; Szalay et al. 1981; Ekman et al. 1983a-c,e; Calder and Greer 1992; Calder 1994; Dong et al. 1996; Chwalisz et al. 1997). Local applications of PGs in animals and humans produce characteristics associated with the ripening process (Ekman et al. 1983a; Chwalisz et al. 1997). PG inhibitors such as Indomethacin, a nonspecific COX inhibitor, prevent spontaneous abortions or preterm labor (Calder 1994; Hearne and Nagey 2000; Shi et al. 2000b; Bukowski et al. 2001). These studies would suggest that PGs play an important role in the ripening of the cervix and parturition.

These and other studies suggest that there may be an interaction between the NO and PG pathways in regulating the NOS and COX expression and this interaction may play a critical role in the control of cervical ripening and parturition (Salvemini et al. 1993; Appleby et al. 1994; Tetsuka et al. 1994; Zhang et al. 1998; Ekerhovd et al. 2002). Specifically, such interactions have been observed in various tissues and models. L-arginine, the substrate for NO production, produces an increase in PGE₂ levels. Both N^G-monomethyl-L-arginine, a nonspecific NOS inhibitor, and aminoguanidine, a specific iNOS inhibitor, decrease PGE₂ levels after lipopolysaccharide stimulation in rat mesangial cells, whereas d-arginine had no effect. Aminoguanidine abolished NO production and decreased PGE₂ production after interleukin (IL)-1β stimulation (Tetsuka et al. 1994). In RAW264.7 cells, PGE₂ levels were also decreased in the presence of N^G-monomethyl-L-arginine and aminoguanidine and in the absence of L-arginine. In RAW264.7 cells with an inactivated L-arginine NO pathway, NO donor sodium nitroprusside and glyceryl trinitrate increased PGE₂ production after arachidonic acid stimulation (Salvemini et al. 1993). Isosorbide 5-mononitrate, another NO-donating compound, stimulated a significant increase in PGE₂ in human cervical specimens (Ekerhovd et al. 2002). Hemoglobin, which binds and inactivates NO, blocked the increase in PGE₂ production induced by L-arginine, NO, sodium nitroprusside, and glyceryl trinitrate. The activation site of COX contains an iron-heme center that NO may interact with to stimulate an increase in COX activity (Salvemini et al. 1993). These studies suggest a potential role for NO in the regulation of COX expression or activation and PG production.

Similarly, PGs, depending on type and concentration, may stimulate NOS expression or activation and NO production. PGs may influence NO activity through secondary messenger systems. Forskolin, which activates adenylate cyclase, increases nitrite or nitrate production, the byproduct of NO metabolism, in IL-β-induced rat mesangial cells. PGI₂ activates adenylate cyclase, converting ATP to cAMP, which in turn may stimulate iNOS expression and NO production (Tetsuka et al. 1994). PGE₂ may downregulate iNOS expression through changes in Ca⁺², cAMP, or the protein kinase C pathways. Indomethacin enhances IL-1β-induced nitrite production by inhibiting PGE₂ release, and increases IL-1β-induced steady-state iNOS mRNA levels and NO production. The effect of Indomethacin is reversed by exogenous PGE₂ (Tetsuka et al. 1994). However, other studies show that PGE₂ increases iNOS expression and NO production, suggesting that the effect of PGs on NOS expression and NO production may be concentration-dependent (Corbett et al. 1993; Salvemini et al. 1993; Franchi et al. 1994; Salvemini et al. 1994; Murakami et al. 1997). Carba-prostacyclin, a stable analog of PGI₂, increased iNOS mRNA levels and IL-1β-induced NO production. The action of PGI₂ may be mediated through the activation of adenylate cyclase. In mesangial and vascular smooth muscle cells, agents that increase cAMP also enhanced the cytokine-induced iNOS induction (Tetsuka et al. 1994). It has been shown that IL-1β stabilizes COX-2 mRNA by phosphorylation of cytosolic factors that bind to the AUUUA-rich 3′ end of COX-2. The iNOS mRNA has an AUUUA 3′ motif in the untranslated region that is considered to be an mRNA instability determinate. PGs may have similar effects to that of IL-1β stabilizing iNOS (Srivastava et al. 1994; Tetsuka et al. 1994). These studies suggest a possible interaction between NOS and COX expression. Similar interactions may be involved in the control of cervical ripening and parturition.

The objective of these studies is to examine the relationship between iNOS and COX-2 in the control of cervical ripening and parturition under normal (normal term pregnancy) and abnormal (preterm labor and prolongation of pregnancy) conditions. First, under normal conditions, we characterize the change in the collagen both visually and quantitatively (picrosirius red polarization method). We also localize (immunohistochemical staining) and characterize (RT-PCR) the expression patterns of iNOS and COX-2 during the ripening process and parturition in the rat cervix. Localization may suggest a spatiotemporal relationship between the iNOS and COX-2 enzymes. Characterization of the expression pattern quantitatively may suggest a relationship between the iNOS and COX-2 mRNA expression. Then, under abnormal conditions, we characterize the expression patterns of iNOS and COX-2: first, under preterm laboring conditions induced with the antiprogestin, Onapristone (ZK98299) and, second, after the prolongation of pregnancy with progesterone. Onapristone is used as a model for progesterone withdrawal and preterm labor (Edwards et al. 1995). Characterization of the expression pattern quantitatively may suggest a relationship between the iNOS and COX-2 mRNA expression under preterm laboring conditions. In contrast, progesterone is used as a model for the prolongation of pregnancy in which progesterone withdrawal does not occur. Characterization of the expression pattern quantitatively may suggest a relationship between the iNOS and COX-2 mRNA expression during the prolongation of pregnancy. Finally, the iNOS and COX-2 mRNA is compared under term vs preterm laboring conditions examining the role or importance of NO and PGs in regulating or initiating parturition. A better understanding of the mechanisms that regulate the ripening process and parturition may result in improved therapeutic and diagnostic options in both preterm cervical insufficiency and failure of cervical ripening at term.

Materials and Methods

Animal Treatment

Nonpregnant and timed-pregnant Sprague-Dawley rats (Charles River Laboratories; Wilmington, MA) were housed separately and allowed free access to food and water. Animals were maintained on a constant 12 hr light and dark cycle. Animals were killed by CO₂ inhalation according to the protocols approved by the Animal Care and Use Committee at the University of Texas Medical Branch.

Tissue Preparation

Normal Term Pregnant Conditions. Cervices were obtained on days 14 (mid-gestation), 18 (late gestation), 22 nonlabor, and labor (one to three pups expelled) of pregnancy, and days 1 and 3 postpartum. Nonpregnant rat cervices obtained at estrus were used as control.

Preterm Labor. Cervices were obtained from timed pregnant Sprague-Dawley rats at 6, 12, 24, and 28 hr after Onapristone (3 mg/rat SC) or vehicle control (200 μl of benzyl benzoate [1]: sesame oil [4] solution) (Sigma; St. Louis, MO) treatment on day 17 of gestation (n=5-6 per group).

Prolongation of Pregnancy. Timed-pregnant rats were chronically treated with either progesterone (2.5 mg SC twice daily) or vehicle starting on day 18 of pregnancy. The animals were sacrificed 1 (control only, reference), 2, 3, 4, or 6 days after the initial treatment (n=6 per group).

Tissue Embedding for Immunohistochemistry (IHC) and the Picrosirius Red Polarization Method. The tissue was fixed in 4% paraformaldehyde in 0.1M phosphate buffer saline with CaCl₂ for 30 min to an hour, trimmed, cut into longitudinal sections, and stored overnight in 0.1M phosphate buffer saline with CaCl₂ at 4C. The tissue was then dehydrated, embedded in paraffin, sectioned at 5-6 μm, and placed on Superfrost/Plus microscope slides (Fisher Scientific; Fairlawn, NJ). The charged slide surface retains the tissue sections. Slides were dried at 60C for 30–45 min and stored at room temperature.

Preparation of RNA. Other cervical tissues were dissected, frozen in liquid nitrogen, and stored at −70C. Total RNA was extracted from the frozen tissue using the acid-guanidinium thiocyanate-phenol-chloroform method (Chomczynski and Sacchi 1987). All samples were treated with DNase I (Stratagene; La Jolla, CA) to remove any contaminating genomic DNA. The amount of RNA was calculated using the A₂₆₀ value.

Visualizing and Measuring the Changes in Rat Cervical Collagen Using the Picrosirius Polarization Method

For picrosirius staining, sections were deparaffinized in xylene (EM Science; Gibbstown, NJ), rehydrated in a series of ethanol solutions (Fisher Scientific), and washed in running water for 10 min. Thorough washing of the sections before staining is essential because it allows the large Sirius red F3BA molecule to penetrate the connective tissue fibers.

Sections are stained with picrosirius red F3BA solution (Direct Red 80; Aldrich, Milwaukee, WI) (0.1% Sirius red F3BA in saturated aqueous picric acid) for 30 min. The dye solution must stand for 24 hr before being used. Positive connective tissue staining, except for elastic connective tissues, is indicated with a deep red colorization. All other tissue structures stain bright yellow (Figure 1) (Sweat et al. 1964). Tissues were dehydrated, cleared, and mounted using Cytoseal 60 (Fisher Scientific).

Sections were viewed with an Olympus U-STP polarizing light microscope (Olympus America; Melville, NY) (Figure 1; Sweat et al. 1964; Junqueira et al. 1979). An OLY-200 digital camera (Olympus America) was used with Adobe Premier 5.1 software (Adobe Systems Inc; San Jose, Ca) to obtain 10 (100x) low-power field images from the circular collagen of each cervix (Figure 1). The shutter speed (1/250 sec) and light source were fixed to compare brightness of the collagen birefringence between groups. As the crosslinks break down, the long strings of collagen are lost, reducing the ability of the collagen to reflect the polarized light. Images were analyzed for mean luminosity using the Adobe Photoshop 5.0 software (image: histogram; Adobe Systems Inc).

Localization of iNOS and COX-2 in Rat Cervical Tissue Using Immunohistochemical Staining

Standard IHC procedures were conducted. Sections were deparaffinized in xylene (EM Science), and ethyl alcohol (reagent grade; Pharmco, Brookfield, CT), and rehydrated in a graded series of ethanol solutions (95%, 70%, 50%) (Fisher Scientific). Sections were treated with 0.3% hydrogen peroxide to quench endogenous peroxidase activity and permeabilized with 0.1% Triton X-100 (Fisher Scientific) in PBS (pH 7.5). Nonspecific binding was blocked by incubating sections in PBS buffer (0.1 M) containing 0.025% BSA Type C (Sigma) and 5% normal horse serum (GIBCO Laboratories; Chagrin Falls, OH).

Figure 1

Picrosirius red staining under light microscopy (25x) and polarized light (100x). This is a digital image of the collagen stained with the picrosirius red that provides a representative indication of where the samples were obtained in the rat cervical tissues throughout gestation. The figure is of the estrus cervix. The arrows indicate where the two cervical canals are located. The black boxes indicate the approximate region within the tissue from which the samples were obtained.

iNOS. Sections used to detect iNOS expression were incubated overnight at 4C in rabbit polyclonal anti-iNOS antibody (Transduction Laboratories; Lexington, KY) at a 1:50 dilution. Sections were rinsed in PBS and then incubated with a biotinylated secondary antibody (Zymed Laboratories; San Francisco, CA). Aminoethyl carbazole (Zymed Laboratories) served as the chromagen to localize the iNOS enzyme.

COX-2. Sections used to localize the COX-2 enzyme expression were incubated for one hour at 37C with a goat polyclonal anti-COX-2 antibody (Santa Cruz Biotechnology; Santa Cruz, CA), at a 1:50 dilution. Sections were rinsed in PBS and then incubated with a biotinylated secondary antibody (Vector Laboratories; Burlingame, CA). Sections were then rinsed in PBS and incubated in an avidin-biotinylated peroxidase complex using the Vectastain Kit. 3,3′-Diaminobenzidine served as a chromagen to localize the COX-2 enzyme.

Sections of both iNOS and COX-2 preparations were lightly counterstained with Harris Modified Hematoxylin containing acetic acid (Fisher Scientific). The excess hematoxylin was removed with an acid-alcohol dip (0.5 ml HCl to 49.5 ml 70% ETOH) and then rinsed in ammonia water (2-3 drops of NH₄OH to 50 ml of distilled water). Tissues were dehydrated in graded alcohol, placed in xylene, and mounted with either GVA mounting solution (Zymed Laboratories Inc.) for iNOS or Cytoseal 60 (Fisher Scientific) for COX-2.

IHC was performed for descriptive, but not quantitative purposes. Numerous sections were examined and representative tissues were photographed using a Nikon Microscope (FXA EP1-FL3; Nikon Microphot, Tokyo, Japan). Tissues from a minimum of four animals were examined at each time point with the distal portion of the cervix evaluated.

Using Real-time RT-PCR to Characterize the iNOS and COX-2 Cervical mRNA Expression

Primers and probes (Table 1) specific for either iNOS or COX-2 were designed using the Primer Express software (Applied Biosystems, Foster City, CA) with the rat iNOS (Acc # L12562) and COX-2 (Acc #L20085) as reference sequences. The selected primers and probes served as queries in blast analyses to confirm specificity (reference identification number: iNOS–forward primer 988309628-20826-3898, reverse primer 988310400-814-12100, and probe 1049152419-02113-5929; COX-2 - forward primer 961013803-12918-21846, reverse primers 1049149992-02684-14705, and probe 1049153173-010389-12316).

Table 1

Primers and probe concentration and sequence information specific for iNOS and COX-2

Gene	Gene bank accession no.	Primer/probe concentrations	Nucleotide position	Nucleotide sequence
iNOS	L12562	Forward (50 nM)	1672-1692	5′-GTGCTAATGCGGAAGGTCATG-3′
		Reverse (300 nM)	1725-1748	5′-GCTTCCGACTTTCCTGTCTCAGTA-3′
		Probe (200 nM)	697-1718	5′-CCCGCGTCAGAGCCACAGTCCT-3′
COX-2	L20085	Forward (900 nM)	1680-1701	5′-GTGTCCCTTTGCCTCTTTCAAT-3′
		Reverse (900 nM)	1732-1751	5′-GAGGCACTTGCGTTGATGGT-3′
		Probe (200 nM)	1686-1730	5′-AAGACCCGCAGCCTACCAAGACAGC-3′

One-step RT-PCR assays were carried out using reagents provided in a TaqMan PCR Core Kit along with an RNase inhibitor and a Multiscribe Reverse Transcriptase (Applied Biosystems; Foster City, CA). Final primer and probe sequences and concentrations for iNOS and COX-2 are listed in Table 1. The iNOS 18SrRNA concentration was 25 nM each for the forward and reverse primers and probe. The COX-2 18SrRNA concentration was 50 nM each for the forward and reverse primers and probe. Each sample contained 100 ng of total RNA in a final volume of 50 μl and was reverse transcribed for 30 min at 48C, followed by AmpliTaq Gold activation (Applied Biosystems) at 95C for 10 min. Real-time PCR amplification was measured by the ABI Prism 7700 Sequence detection System (Applied Biosystems) under the following conditions: denaturation at 95C for 15 sec and annealing/extension at 60C for 1 min for 40 cycles.

Tissues from 4 to 10 animals were analyzed in each experimental group. Relative RNA levels were calculated using the ΔC_T method described in Taqman Users Bulletin #2 (Applied Biosystems). The data were normalized against the internal 18SrRNA control (Applied Biosystems). Results are expressed as the average % of cervical iNOS or COX-2 mRNA expression relative to the levels of the estrus cervix (normal term pregnant study); the 6-hr control cervix (Onapristone study/preterm labor); the day 19 control cervix (progesterone study/prolongation of pregnancy); or the estrus cervix (term labor), the 28-hr control cervix (preterm labor) and the cervix at estrus (comparing term vs preterm labor) ± SEM.

Statistical Analysis

Statistical comparison between groups was performed using a one-way ANOVA followed by either the Student-Newman-Keuls test (picrosirius polarization study) or a Tukey test for multiple comparisons and a Spearman's correlation (normal term pregnant study and Onapristone/preterm labor study); a two-way ANOVA followed by a Tukey test (progesterone/prolongation of pregnancy) (significance: p<0.05); or a t-test or a Mann-Whitney Rank Sum Test (term versus preterm labor comparison study-normal/term: iNOS p=0.022, COX-2 p=0.01; Onapristone/preterm: iNOS p=0.005, COX-2 p=0.004; term versus preterm: iNOS p=0.004, COX-2 p=0.874 (Sigma Stat; Jandel Scientific Software, San Rafael, CA).

Results

Visualizing and Measuring the Changes in the Collagen

Figure 1 provides a representative indication of where the samples were obtained in the rat cervical tissues throughout gestation. It also demonstrates staining with the picrosirius red under light microscopy (25x) and polarized light (100x).

The changes in the organization of the collagen are visualized based on changes in the birefringence of the collagen (Figure 2). Luminosity is used to measure changes in the collagen based on the brightness of the birefringence (Figure 3). There is a progressive decrease in the organization reflected by the loss of birefringent intensity of the collagen from the nonpregnant state (Figure 2A), through pregnancy (Figures 2B–2D), which then appears to increase in the postpartum cervix (Figures 2E and 2F). In samples from the estrus (Figure 2A) and day 14 (Figure 2B) cervix, the collagen appears to be dense and highly organized with a high birefringence (Figure 3). On day 18 of gestation (Figure 2C), term (Figure 2D) and postpartum day 1 (Figure 2E) cervix, the collagen appears to be dispersed and disorganized with a significantly low birefringence (Figure 3). The birefringence (Figure 3) and the organization of the collagen within the cervix appeared to return to estrus levels (Figure 2A) in the postpartum day 3 cervix (Figure 2F).

Localization of Cervical iNOS and COX-2 during Gestation

Controls for iNOS and COX-2. Figures 4A1–4A3 is the control tissues for the localization of the iNOS enzyme using immunohistochemical staining. Rat liver was used for the iNOS IHC positive control (Figure 4A1) A red to brown reaction product is an indication of positive staining for the iNOS enzyme. Normal rabbit IgG (Santa Cruz Biotechnology) was substituted for the primary antibody (Figure 4A2, rat liver) or the primary antibody was omitted in the negative control sections (Figure 4A3, estrus rat cervix).

Figure 2

Changes observed were based on the organization and birefringence of the picrosirius red-stained collagen within the rat cervix throughout gestation using digital images (100X). (A) Nonpregnant estrus, (B) day 14, (C) day 18, (D) day 22, (E) postpartum day 1, and (F) postpartum day 3 (n=4 per group).

Figures 5A1-5A3 is the control tissues for the localization of the COX-2 enzyme using immunohistochemical staining. Day 22 laboring (D22L) rat uterus or kidney was used for COX-2-positive control sections (Figure 5A1, D22L rat uterus). A brown reaction product is an indication of positive staining for the COX-2 enzyme. Normal goat IgG (Santa Cruz Biotechnology) was substituted for the primary antibody (Figure 5A2, D22L rat uterus) or the primary antibody was omitted in the negative control sections (Figure 5A3, estrus rat cervix).

iNOS. Figures 4B1-4B7 are representative tissues demonstrating the localization sites for the iNOS enzyme throughout gestation in the rat cervix. Labeling for iNOS was evident in the cervical tissues at all time points examined. The iNOS enzyme was most prominent in the cervical smooth muscle (Figure 4B and Figure 6B). Expression of iNOS was also localized in the vascular smooth muscle (Figure 4B2 and Figure 6A). There was also labeling of large leukocyte or monocyte-like cells (Figure 6C). Epithelial labeling occurred in the postpartum day 1 cervix (Figure 4B6 and Figure 6E) and occasionally in the laboring cervix (Figure 6D). iNOS in the estrous cervix was present in the cervical smooth muscle, the vascular smooth muscle, the epithelium, and within a band of unknown cells located in the stroma, possibly fibroblasts (Figure 4B1 and Figure 6F).

Figure 3

Changes in the rat cervical collagen during the ripening process measured by the picrosirius polarization method. The changes in the collagen are measured based on the luminosity of collagen as pregnancy progressed to term and the cervix ripened. Statistical comparison between the groups was performed using a one-way ANOVA followed by the Student-Newman-Keuls test. ^∗Indicates significance of p<0.001. (NP: non-pregnant estrus; D14: day 14; D18: day 18; D22: day 22; PP1: postpartum day 1; PP3: postpartum day 3; n=4 per group).

COX-2. Figures 5B1-5B7 is representative tissues demonstrating the localization sites for the COX-2 enzyme throughout gestation in the rat cervix. Labeling for COX-2 was present in the cervical tissues at all time points examined. The COX-2 enzyme was mainly localized in the cervical smooth muscle (Figure 5B and Figure 6G). Expression of COX-2 was also localized in the vascular smooth muscle (Figure 5B and Figure 6I). Epithelial labeling occurred in the laboring cervix (Figure 5B5 and Figure 6H). The estrous cervix had label for the COX-2 enzyme in the cervical smooth muscle, the vascular smooth muscle, and within the epithelium (Figure 5B1).

Cervical iNOS and COX-2 mRNA Expression during Gestation

iNOS. The iNOS mRNA expression decreased as pregnancy progressed to term with the highest levels occurring in the nonpregnant and postpartum cervix and the lowest levels occurring at day 18 (Figure 7A), although the differences were not statistically significant.

COX-2. There was about a 50-fold increase in COX-2 mRNA expression in the day 22 laboring cervix compared with estrus, followed by a more than 19-fold decrease in the postpartum day 3 cervix (p<0.05; Figure 7A).

Figure 4

(A1-3) Control tissues for the localization of the iNOS enzyme using immunohistochemical staining. (A1) The positive control for iNOS is the rat liver (525X). (A2) Negative control includes utilization of a nonreactive IgG on the rat liver (525X) and (A3) staining of a longitudinal section of the estrus cervix omitting the primary antibody (265X). (B1-7) Localization sites for the iNOS enzyme throughout gestation in longitudinal sections of the rat cervix. (B1) NPE: nonpregnant estrus; (B2) D14: day 14; (B3) D18: day 18; (B4) D22NL: day 22 nonlabor; (B5) D22L: day 22 labor (tissue collected within the birth of one to three pups); (B6) PP1: postpartum day 1; and (B7) PP3: postpartum day 3 (130X). A reddish brown staining is a positive indication for the iNOS enzyme. iNOS is mainly localized in the cervical smooth muscle throughout gestation. iNOS is also localized in the vascular smooth muscle through gestation. Epithelial staining always occurred in the PP1 cervix, but occasionally occurred in the day 22 laboring cervix. iNOS staining was also observed in a large leukocyte/monocyte like cell throughout gestation. A minimum of four animals were used per group.

iNOS and COX-2. There is a significant inverse relationship between iNOS and COX-2 mRNA expression (Spearman r=-0.497; p=0.00295) (Figure 7B).

Cervical iNOS and COX-2 mRNA Expression After Induction of Preterm Labor with the Antiprogestin Onapristone (ZK98299)

Onapristone. Treatment with Onapristone stimulated preterm labor, reducing the duration of the pregnancy. The vehicle control rats did not deliver early, whereas the Onapristone treated rats were in labor or delivering preterm 28 hr after the initial treatment on the 18th day of gestation.

iNOS. Expression of the iNOS mRNA gradually increased 6, 12, 24, and 28 hr after Onapristone treatment in the day 17 rat cervix. iNOS mRNA levels peaked 28 hr after treatment with Onapristone (Figure 8A). This peak was significantly different from all the control groups (p<0.05).

Figure 5

(A1-3) Control tissues for the localization of the COX-2 enzyme using immunohistochemical staining. (A1) The positive control for COX-2 is the day 22 laboring rat uterus (525X). (A2) Negative control includes use of a nonreactive IgG on the day 22 laboring rat uterus (525X) and (A3) staining of a longitudinal section of the estrus cervix omitting the primary antibody (265X). (B1-7) Localization sites for the COX-2 enzyme throughout gestation in longitudinal sections of the rat cervix. (B1) NPE: nonpregnant estrus; (B2) D14: day 14; (B3) D18: day 18; (B4) D22NL: day 22 nonlabor; (B5) D22L: day 22 labor (tissue collected within the birth of one to three pups); (B6) PP1: postpartum day 1; and (B7) PP3: postpartum day 3 (130X). A brown reaction product is a positive indication for the COX-2 enzyme. COX-2 is mainly localized in the cervical smooth muscle throughout gestation. COX-2 is also localized in the vascular smooth muscle through gestation. Epithelial staining always occurred in the D22L cervix. A minimum of four animals were used per group.

COX-2. Expression of the COX-2 mRNA gradually increased 6, 12, 24, and 28 hr after Onapristone treatment in the day 17 rat cervix. COX-2 mRNA levels peaked 28 hr after treatment with Onapristone (Figure 8A). This peak was significantly different from all groups except for the 24 hr-treated group (p<0.05).

iNOS and COX-2. A significant correlation between iNOS and COX-2 was demonstrated (Spearman r = 0.456; p=0.03; n=23) (Figure 8B), indicating that as iNOS increased, so did COX-2 after treating with Onapristone; and the increase in iNOS and COX-2 was associated with preterm labor.

Cervical iNOS and COX-2 mRNA Expression After the Prolongation of Pregnancy with Progesterone

Progesterone. Treatment with progesterone inhibited term labor, prolonging the pregnancy. The vehicle control rats delivered at term (day 22), whereas the progesterone treated rats remained pregnant even after 6 days of treatment.

Figure 6

Representative pictures of iNOS (A-F) and COX-2 (G-I) are localized in longitudinal sections of the rat cervix throughout gestation at an increased magnification (265X) using immunohistochemical staining. iNOS: (A) D14: day 14, vascular smooth muscle labeling; (B) D22NL: day 22 nonlabor, cervical smooth muscle labeling; (C) D22NL: labeling of a leukocyte/monocyte-like cell; (D) D22L: day 22 labor, occasional epithelial labeling; (E) PP1: postpartum day 1, epithelial labeling (130X); (F) NPE: nonpregnant estrus, a discrete unknown band of stromal cells; COX: (G) D22L: cervical smooth muscle labeling; (H) D22L: epithelial labeling; and (I) D22L, vascular smooth muscle labeling. A reddish brown staining is a positive indication for the iNOS enzyme (A-F) and a brown reaction product is a positive indication for the COX-2 enzyme (G-I). A minimum of four animals were used per group.

iNOS. In animals treated with progesterone, iNOS mRNA expression appeared to be reduced and maintained at a low and consistent level (Figure 9). However, the decrease was not significant.

COX-2. In animals treated with progesterone, COX-2 mRNA expression was maintained at a low and consistent level, demonstrating a significant (p=0.036) decrease in the treated vs the nontreated groups. COX-2 mRNA expression was significantly (p<0.001) decreased at day 20 in the treated vs the nontreated group (Figure 9). COX-2 significantly increased in the day 20 nontreated group compared with the day 21 (p<0.001), 22 nonlabor (p=0.001), and postpartum day 2 (p=0.005) nontreated rat cervix. The increase in COX-2 on day 20 of gestation in the cervix may be due to an increase in leukocyte infiltration or epithelial expression.

Cervical iNOS and COX-2 mRNA Expression during Both Term and Preterm Laboring Conditions

At term in the day 22 laboring rat cervix, iNOS mRNA significantly decreased (p=0.022), whereas COX-2 mRNA significantly increased (p= 0.011) (Figure 10A). The expression of iNOS (p= 0.005) and COX-2 (p= 0.004) mRNA was significantly increased during labor under preterm laboring conditions, 28 hr after treatment (Onapristone) compared with the 28-hr control cervix (Figure 10B). During preterm vs term labor, iNOS mRNA was significantly increased (p=0.004); however, there was no difference in the COX-2 mRNA levels (Figure 10C).

Figure 7

(A) The expression patterns of iNOS and COX-2 mRNA in the rat cervix throughout gestation. The data are expressed as the average % of cervical iNOS or COX-2 mRNA relative to the non-pregnant estrus cervix compared with gestational time. RNA levels were detected by real-time analysis and calculated as described in the materials and methods section. Statistical comparison between the groups was performed using a one-way ANOVA followed by a Tukey test for multiple comparisons (p<0.05 is significant). Different letters are an indication of statistical significance (4-10 animals per group). (B) A Spearman's correlation was performed on the iNOS and COX-2 mRNA data under normal term pregnant conditions in the rat cervix demonstrating a significant inverse correlation. The iNOS mRNA expressed decrease as the COX-2 mRNA increases as pregnancy progressed to term and the cervix ripened. (Spearman r =-0.497; p=0.00295; n=34).

Discussion

Preterm labor and birth is the leading cause of infant mortality. It is responsible for 75% of all infant mortality and 50% of long-term neurologic disorders (Berkowitz and Papiernik 1993; Creasy 1993; Simpson 1997; Goldenberg and Rouse 1998). Given these statistics, a better understanding of the mechanisms that regulate cervical ripening and parturition under normal (normal term pregnancy) and abnormal (preterm labor and the prolongation of pregnancy) conditions is critically important for our understanding of the pathogenesis of these conditions and possible development of new therapeutic interventions. Treatments that could prolong pregnancy, preventing premature birth, could have a profound effect on fetal mortality and the family unit (Iams 1995).

Our studies examine the relationship between iNOS and COX-2 in the control of cervical ripening and parturition under both normal (normal term pregnancy) and abnormal (preterm labor and the prolongation of pregnancy) conditions. This is accomplished by first characterizing, both visually and quantitatively, the changes taking place in the collagen. Second, is through the localization and characterization of iNOS and COX-2 expression under normal conditions during the different stages of the ripening process and parturition; and third, is by characterizing the changes in the iNOS and COX-2 mRNA expression in the rat cervical tissues during pregnancy under abnormal conditions. Our data suggest that as pregnancy progresses to term, there is a steady decrease in the birefringence and organization of the collagen. Quantitatively, the decrease in the birefringence and the organization of the collagen is associated with a decrease in the luminosity. This indicates that as pregnancy progresses to term there is a progressive decrease in the crosslinked collagen and the long collagen fiber strands. Our data suggest that the mechanisms regulating cervical ripening and parturition may differ under term vs preterm laboring conditions. Specifically, under normal term pregnant conditions, there may not be a relationship between the NO and PG pathways. They may act independently of each other in regulating the iNOS and COX-2 mRNA expression in the control of cervical ripening and parturition. Under normal conditions, the iNOS and COX-2 enzymes were colocalized in the cervical smooth muscle, the vascular smooth muscle, and epithelium at similar times during gestation. The iNOS mRNA levels had a tendency to decrease, whereas COX-2 mRNA levels increased as pregnancy progressed to term, demonstrating an inverse relationship. The data under abnormal conditions suggest that under preterm laboring conditions, there is a relationship between iNOS and COX-2 expression in the control of cervical ripening and parturition. Also, the data suggest that progesterone may play a role early on in the relationship between iNOS and COX-2 in regulating the mRNA expression and parturition. Under abnormal conditions, progesterone prolonged pregnancy and appeared to cause a decrease in iNOS and COX-2 mRNA expression. Onapristone stimulated preterm parturition and produced a parallel increase in iNOS and COX-2 mRNA expression, demonstrating a positive correlation. The data on term vs preterm parturition indicate that PGs are important for parturition. However, NO may play a more important role under preterm labor conditions possibly working through PGs. The data also indicate there may need to be a peak in PGs levels for parturition to occur. This suggests that if the peak occurs, early preterm labor is initiated; if the peak does not occur, the pregnancy is prolonged. At term, under normal laboring conditions (at parturition), iNOS mRNA decreased, whereas COX-2 increased. In contrast, under preterm laboring conditions (at parturition), both iNOS and COX-2 mRNA increased. When comparing term with preterm parturition, there was no change in the COX-2 mRNA expression, but there was a significant increase in iNOS mRNA expression under preterm laboring conditions.

Figure 8

(A) iNOS and COX-2 mRNA expression in rat cervical tissues treated on day 17 with Onapristone (antiprogestin, ZK98299). The data are expressed as the average % of cervical iNOS or COX-2 mRNA relative to the 6-hr control cervix compared with time. RNA levels were detected by real-time analysis and calculated as described in the Materials and Methods section. Statistical comparison between the groups was performed using a one-way ANOVA followed by a Tukey test for multiple comparisons (p<0.05 is significant). Different letters are an indication of statistical significance (five to six animals per group). (B) A Spearman's correlation was preformed on the iNOS and COX-2 mRNA data under preterm laboring conditions after treating with the antiprogestin Onapristone in the rat cervix, which demonstrated a positive correlation. This means that as the iNOS mRNA increased, so did the COX-2 mRNA after being treated with Onapristone; and the increase was associated with preterm laboring conditions. (Spearman r = 0.456; p=0.03; n = 23).

Our studies indicate that, under polarized light, the picrosirius red F3BA dye can be used to visualize and measure changes in the collagen during the ripening process and parturition. These changes can be correlated with various treatments or changes in the expression of various enzymes that occur during pregnancy. In our studies, there was a decrease in the organization and birefringence of the cervix as pregnancy progressed to term (Figure 2 and Figure 3). This is comparable to previous studies showing a decrease in cervical resistance and light-induced fluorescence as pregnancy progresses to term and the cervix ripens (Shi et al. 1999). Tissue taken from the fibrous core of the human cervix demonstrated an increase in the distensibility during pregnancy compared with the nonpregnant cervix (Conrad and Ueland 1983). This suggests that as pregnancy progresses to term, the cervix becomes soft and pliable, indicating the importance of collagen and changes in collagen in the ripening of the cervix and parturition (Danforth 1980; Conrad and Ueland 1983; Shi et al. 1999).

Our studies, and other studies, indicate that the ripening of the cervix is a continual process that occurs throughout gestation, preparing the cervix for delivery and a successful end to pregnancy (Conrad and Ueland, 1983; Shi et al., 1999). The human cervix is clinically soft several weeks before parturition, but remains closed with a high tensile strength, possibly because of the length or orientation of the collagen fibers (Yu et al. 1995). Our studies show that in the rigid cervix (Figure 2; estrus, day 14, postpartum 3), collagen is oriented as bundles of long fibers, suggesting a high tensile strength (Vidal et al. 1982; Leppert and Yu 1994; Yu et al. 1995; Shi et al. 1999). This is lost late in gestation when the cervix is already soft (Figure 2; day 18, 22, and postpartum 1 cervix). The long strands of collagen are gone, replaced by aggregates of much shorter and thinner fibers and a decreased birefringence. With a change in the orientation of the collagen, the cervix is now soft, and effacement and dilation can occur (Vidal et al. 1982; Leppert and Yu 1994; Yu et al. 1995). This suggests that the orientation and the length of the collagen fibers are important in maintaining the rigidity of the cervix and play an important role in the ripening process during pregnancy.

Figure 9

The expression of iNOS and COX-2 mRNA in rat cervical tissues after prolongation of pregnancy with progesterone. The data are expressed as the average % of cervical iNOS or COX-2 mRNA relative to the day 19 control cervix compared with gestational time. Statistical comparison between the groups was performed using a two-way ANOVA followed by a Tukey test for multiple comparisons (p<0.05 is significant). Different letters are an indication of statistical significance (five to six animals per group).

There may be a possible interaction between the NO and PG pathways at the protein or product level in the control of enzyme activity of iNOS and COX-2 during cervical ripening and parturition (Corbett et al. 1993; Salvemini et al. 1993; Tetsuka et al. 1994; Swaisgood et al. 1997; Ledingham et al. 1999; Ekerhovd et al. 2002). Our data show the expression of the iNOS and COX-2 enzymes in similar tissues at similar times during gestation, suggesting a possible interaction between the pathways (Figures 4-6). Buhimschi et al. (1996) and Ledingham et al. (2000) showed the iNOS enzyme to be present in the cervix during pregnancy. Dong et al. (1996) showed the COX-2 enzyme to be present in the cervix during pregnancy. Salvemini et al. (1993) and Ekerhovd et al. (2002) showed a potential interaction between iNOS and COX-2 at the protein and product level. Our data support these studies, indicating a possible interaction between the NO and PG pathways at the protein or product level.

At the mRNA level, iNOS had a tendency to decrease, whereas COX-2 increased, demonstrating an inverse relationship (Figures 7A and 7B) (Puri and Garfield 1982; Dong et al. 1996; Fittkow et al. 2001; Tornblom et al. 2005). Fittkow et al. (2001) showed iNOS levels to be low in guinea pigs during pregnancy. Puri and Garfield (1982) showed an increase in the PG levels. Dong et al. (1996) and Fittkow et al. (2001) showed an increase in the COX-2 level. Our data confirm this.

The decrease in iNOS in our study was not significant. This may be due to variability within the physiologic samples (Figure 7A). Other studies report that iNOS or NO increases rather than decreases in the cervix during labor (Buhimschi et al. 1996; Ali et al. 1997; Ledingham et al. 2000). The difference between our results and previous studies may be explained by the time points examined, because most of these studies examined the later stages of gestation. However, compared with the estrous and postpartum tissues, iNOS expression was low during pregnancy (Figure 7A) (Fittkow et al. 2001). Another explanation may be the differences in the techniques, because our lab now uses a much more sensitive real-time RT-PCR system. In addition, previous studies in rat cervical tissues used Sprague-Dawley rats from Harlan, whereas our studies use rats from Charles River. There may be subtle genetic variability in two outbred rat colonies of the same species (Shi et al. 2000a).

The decrease in iNOS and the increase in COX-2 are thought to play a role in regulating matrix metallopeptidase (MMP)-8 and MMP-9 expression in the continued breakdown of the collagen during the ripening process (Winkler et al. 1999). NO is thought to downregulate or inhibit MMP-8 and MMP-9 (Upchurch et al. 2001). The decrease in iNOS expression or NO production may be required to allow an increase in MMP-8 and MMP-9 in the later stages of gestation. The increase in COX-2 expression or PG production may be required for parturition and to allow an increase in IL-8, a chemotactic agent that attracts neutrophils that are known to express MMP-8 and MMP-9 (Chwalisz et al. 1994; El Maradny et al. 1994; Winkler et al. 1999; Elliott et al. 2001; Watari et al. 2003).

Figure 10

A comparison between iNOS and COX-2 mRNA expression during term and preterm laboring conditions. (A) Under term pregnant conditions, the data are depicted as the average % of cervical iNOS or COX-2 mRNA relative to the estrus control cervix. (B) Under preterm laboring conditions, the data are depicted as the average % of cervical iNOS or COX-2 mRNA 28 hr after treatment relative to the 28-hr control cervix. (C) When comparing term vs preterm laboring conditions, the data are depicted as the average % of cervical iNOS or COX-2 mRNA relative to the estrus control cervix. A statistical comparison was performed using either a t-test or a Mann-Whitney Rank Sum Test (term vs preterm labor comparison study; (A) normal/term: iNOS p=0.022, COX-2 p=0.01; (B) Onapristone/preterm: iNOS p=0.005, COX-2 p= 0.004; (C) term vs preterm: iNOS p=0.004, COX-2 p=0.874. Different letters are an indication of statistical significance (4-10 animals per group).

The iNOS and COX-2 mRNA expression appears to increase (Figure 7A; iNOS: at estrus and in the postpartum tissues; COX-2: at labor) primarily at times during pregnancy when epithelial staining for the iNOS and COX-2 enzyme (Figures 4-6) occurs, suggesting that an increase in iNOS and COX-2 may be due to increased epithelial expression (Tschugguel et al. 1999; Tornblom et al. 2005).

Onapristone is shown to ripen the cervix in many animals (Elger et al. 1986; Frydman et al. 1988; Hegele-Hartung et al. 1989; Chwalisz et al. 1991; Chwalisz 1994). In our studies, Onapristone stimulates preterm parturition and produces a parallel increase in the iNOS and COX-2 mRNA expression, demonstrating a positive statistical correlation and suggesting a potential relationship/interaction between the NO and PG pathways under preterm laboring conditions (Figures 8A and 8B) (Nathanielsz 1978a,b; Thorburn and Challis 1979; Puri and Garfield 1982; Buhimschi et al. 1996; Dong et al. 1996; Yallampalli et al. 1996; Ali et al. 1997; Selles et al. 2002; Tornblom et al. 2005). Hegele-Hartung et al. (1989) show that after being treated with an antiprogestin, the collagen fibers become scattered and dissociate from one another. This is associated with stromal edema and an increase in leukocyte infiltration into the cervix. Chwalisz et al. (1997) show a decrease in the cervical resistance after being treated with antiprogestin, NO, or PGs. Ali et al. (1997) show an increase in iNOS expression after treating with an antiprogestin. These studies, and ours, suggest that progesterone plays a role in regulating the ripening of the cervix and parturition, possibly acting through iNOS and COX-2 expression. It also suggests that cervical incompetence or preterm labor may be due to either deficiencies or abnormalities in the PR or a decrease in the progesterone.

In our study, progesterone prolongs pregnancy and decreases the iNOS and COX-2 mRNA expression, maintaining them at a relatively low and consistent level (Figure 9). The decrease in iNOS is not significant, possibly because of the iNOS levels already being low (Figure 7A). Buhimschi et al. (1996) showed a decrease in NO production after being treated with progesterone. This would suggest that progesterone plays a role in the ripening of the cervix and parturition, possibly acting through an increase in NO and PG production. Also, failure of the cervix to ripen or prolongation of the pregnancy may be due to an increase or overexpression of progesterone, its receptors, or a decrease in the NO and PG production (Puri and Garfield 1982; Buhimschi et al. 1996; Dong and Yallampalli 1996; Ali et al. 1997).

There is a peak in the COX-2 mRNA expression that occurs under both term and preterm laboring conditions. The iNOS mRNA expression is only increased under preterm laboring conditions. This suggests that PGs are important for parturition, but that NO may play a more important role under preterm labor conditions—possibly acting through PGs. It also suggests that PGs may need to increase or reach a certain level for parturition to occur (Figure 10) (Chwalisz et al. 1991; Radestad and Bygdeman 1993). Our data suggest that a shift in this peak to an early time point may stimulate preterm parturition (Figure 8A and Figure 10), or if the peak does not occur, pregnancy may be prolonged (Figure 9).

Fibronectin (a determination of the fibronectin protein in the vaginal fluid) and cervical changes are used in predicting preterm labor. However, they have been found to work mainly in high-risk situations. This increase or peak in PGs has the potential to be used as a method, along with fibronectin and changes in the cervix, for predicting preterm labor in both high- and low-risk situations early in pregnancy.

In summary, the goals of our studies were to better understand the relationship/interaction between iNOS and COX-2 in the control of cervical ripening and parturition. A better understanding of how these pathways are regulated may have a significant impact on the development of the diagnostic and therapeutic modalities in treating medical conditions involving pregnancy and birth. The main observations of our studies are that the picrosirius polarization staining method can be used to visualize and measure changes in the organization of the collagen during the ripening process and parturition. The method can also be used to correlate changes in the enzymes with the breakdown of the collagen in the cervix. There is a decrease in the organization and birefringence of the collagen as pregnancy progresses to term in association with the iNOS and COX-2 enzymes being localized within the cervix throughout gestation. This suggests a decrease in the crosslinked collagen and the long collagen fibers. It also suggests that the orientation of the collagen changes, becoming dispersed and disorganized as the cervix softens and that NO and PGs may play an important role in this process. Our data show that there may be an interaction between the NO and PG pathways in the control of cervical ripening and parturition. Progesterone may play a role in regulating the relationship or interaction between the NO and PG pathways early in the ripening process and parturition. Early in the ripening process, when progesterone levels are high, it is thought to decrease and maintain the iNOS and COX-2 levels, the NO and PGs levels at relatively low and consistent level preventing and interaction between the two pathways. However, when progesterone levels decrease in the later stages of gestation, it is thought to cause an increase in the PG levels and, possibly, the NO levels, allowing for an interaction between the two pathways in the control of the ripening process and parturition. This would suggest that under normal conditions, this interaction may not occur, at least in the regulation of the mRNA expression, because an increase in iNOS is not observed. The two pathways may act independently of each other in the ripening of the cervix and parturition under normal conditions, at least at the mRNA level. In contrast, under preterm laboring conditions, there may be an interaction, because an increase in both iNOS and COX-2 is observed in the regulation of the mRNA expression. The NO and PG pathways may interact in regulating the ripening of the cervix and parturition under preterm laboring conditions. Another important novel finding from these studies is that PGs may be involved in regulating parturition under both normal and abnormal conditions. NO may only be involved in regulating parturition under abnormal conditions, such as with preterm labor, possible acting through PGs. We are further defining the role of PGs in the ripening process and parturition, suggesting that PGs are increased under both term and preterm laboring conditions, stimulating parturition; and, when downregulated, the pregnancy is prolonged. These are new and unique findings that represent a significant advance in the literature in understanding the relationship between iNOS and COX-2 in the control of cervical ripening and parturition. In addition, it was previously thought that the mechanisms regulating the ripening processes and parturition, under both normal term and preterm laboring conditions, were the same, but that under preterm laboring conditions, the process was sped up. We demonstrate an inverse relationship between iNOS and COX-2 under normal term pregnant conditions and a direct relationship under preterm laboring conditions. This suggests that the mechanisms regulating the ripening process and parturition under normal term and preterm laboring conditions may differ, but the outcome is the same (an increase in PGs and the fetus being delivered). Finally, the failure of the cervix to ripen or the prolongation of pregnancy or cervical incompetence or preterm labor may be due to problems associated with progesterone or the regulation of iNOS and COX-2 expression (NO and PG production).

Footnotes

Acknowledgements

This study was supported by National Institutes of Health Grant #5 F31 HD-008739.

We express our gratitude to Yakov Pesah, PhD, of Baylor College of Medicine for his help with this work.

References

Ali

Buhimschi

Chwalisz

Garfield

(1997) Changes in expression of the nitric oxide synthase isoforms in rat uterus and cervix during pregnancy and parturition. Mol Hum Reprod 3: 995–1003

Appleby

Ristimaki

Neilson

Narko

Hla

(1994) Structure of the human cyclo-oxygenase-2 gene. Biochem J 302: 723–727

Berkowitz

Papiernik

(1993) Epidemiology of preterm birth. Epidemiol Rev 15: 414–443

Buhimschi

Ali

Jain

Chwalisz

Garfield

(1996) Differential regulation of nitric oxide in the rat uterus and cervix during pregnancy and labour. Hum Reprod 11: 1755–1766

Bukowski

McKay

Shi

Saade

Garfield

(2001) The effects of cervical application of inhibitors of inducible nitric oxide synthase, cyclooxygenase-1, and cyclooxygenase-2 on delivery in rats. Am J Obstet Gynecol 185: 959–965

Calder

(1994) Prostaglandins and biological control of cervical function. Aust N Z J Obstet Gynaecol 34: 347–351

Calder

Embrey

Tait

(1977) Ripening of the cervix with extra-amniotic prostaglandin E2 in viscous gel before induction of labour. Br J Obstet Gynaecol 84: 264–268

Calder

Greer

(1992) Cervical physiology, and induction of labour. In Bonnar

ed. Recent Advances in Obstetrics and Gynecology. New York, Churchill Livingston, 33–56

Chomczynski

Sacchi

(1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159

10.

Chwalisz

(1994) The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod 9(suppl 1):131–161

11.

Chwalisz

Benson

Scholz

Daum

Beier

Hegele-Hartung

(1994) Cervical ripening with the cytokines interleukin 8, interleukin 1 beta and tumour necrosis factor alpha in guinea-pigs. Hum Reprod 9: 2173–2181

12.

Chwalisz

Fahrenholz

Hackenberg

Garfield

Elger

(1991) The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations. Am J Obstet Gynecol 165: 1760–1770

13.

Chwalisz

Shao-Qing

Garfield

Beier

(1997) Cervical ripening in guinea-pigs after a local application of nitric oxide. Hum Reprod 12: 2093–2101

14.

Conrad

Ueland

(1983) Physical characteristics of the cervix. Clin Obstet Gynecol 26: 27–36

15.

Corbett

Kwon

Turk

McDaniel

(1993) IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 32: 13767–13770

16.

Creasy

(1993) Preterm birth prevention: where are we? Am J Obstet Gynecol 168: 1223–1230

17.

Danforth

(1980) Early studies of the anatomy, and physiology of the human cervix—and implications for the future. In Naftolin

Stubblefield

Phil

ed. Dilatation of the Uterine Cervix Connective Tissue Biology and Clinical Management. New York, Raven Press, 3–15

18.

Danforth

Veis

Breen

Weinstein

Buckingham

Manalo

(1974) The effect of pregnancy and labor on the human cervix: changes in collagen, glycoproteins, and glycosaminoglycans. Am J Obstet Gynecol 120: 641–651

19.

Dong

Gangula

Fang

Yallampalli

(1996) Differential expression of cyclooxygenase-1 and −2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins 52: 13–34

20.

Dong

Yallampalli

(1996) Interaction between nitric oxide and prostaglandin E2 pathways in pregnant rat uteri. Am J Physiol 270: E471–E476

21.

Edwards

Altmann

DeMarzo

Zhang

Weigel

Beck

(1995) Progesterone receptor and the mechanism of action of progesterone antagonists. J Steroid Biochem Mol Biol 53: 449–458

22.

Ekerhovd

Weijdegard

Brannstrom

Mattsby-Baltzer

Norstrom

(2002) Nitric oxide induced cervical ripening in the human: involvement of cyclic guanosine monophosphate, prostaglandin F(2 alpha), and prostaglandin E(2). Am J Obstet Gynecol 186: 745–750

23.

Ekman

Forman

Marsal

Ulmsten

(1983a) Intravaginal versus intracervical application of prostaglandin E2 in viscous gel for cervical priming and induction of labor at term in patients with an unfavorable cervical state. Am J Obstet Gynecol 147: 657–661

24.

Ekman

Perssen

Ulmsten

Wingerup

(1983b) The impact on labor induction of intracervically applied PGE2-gel, related to gestational age in patients with an unripe cervix. Acta Obstet Gynecol Scand Suppl 113: 173–175

25.

Ekman

Uldbjerg

Malmstrom

Ulmsten

(1983c) Increased postpartum collagenolytic activity in cervical connective tissue from women treated with prostaglandin E2. Gynecol Obstet Invest 16: 292–298

26.

Ekman

Uldbjerg

Wingerup

Ulmsten

(1983d) Intracervical instillation of PGE2-gel in patients with missed abortion or intrauterine fetal death. Arch Gynecol 233: 241–245

27.

Ekman

Ulmsten

Wingerup

(1983e) Intracervical application of PGE2-gel combined with early intravenous infusion of oxytocin for induction of term labor in women with unripe cervix. Arch Gynecol 234: 61–65

28.

El Maradny

Kanayama

Halim

Maehara

Sumimoto

Terao

(1994) Interleukin-8 induces cervical ripening in rabbits. Am J Obstet Gynecol 171: 77–83

29.

Elger

Beier

Chwalisz

Fahnrich

Hasan

Henderson

Neef

(1986) Studies on the mechanisms of action of progesterone antagonists. J Steroid Biochem 25: 835–845

30.

Elliott

Allport

Loudon

Bennett

(2001) Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. Mol Hum Reprod 7: 787–790

31.

Fittkow

Wentz

Saade

Garfield

(2001) Expression of iNOS and COX2 in guinea pig cervices during gestation. J Soc Gynecol Investig 8: 770

32.

Forman

Ulmsten

Banyai

Wingerup

Uldbjerg

(1982a) Evidence for a local effect of intracervical prostaglandin E2-gel. Am J Obstet Gynecol 143: 756–760

33.

Forman

Ulmsten

Wingerup

Banyai

(1982b) Effects of intracervical PGE2-gel on myometrial activity and cervical state in first trimester pregnancy. Prostaglandins 24: 303–312

34.

Franchi

Chaud

Rettori

Suburo

McCann

Gimeno

(1994) Role of nitric oxide in eicosanoid synthesis and uterine motility in estrogen-treated rat uteri. Proc Natl Acad Sci USA 91: 539–543

35.

Frydman

Fernandez

Pons

Ulmann

(1988) Mifepristone (RU486) and therapeutic late pregnancy termination: a double-blind study of two different doses. Hum Reprod 3: 803–806

36.

Gilbert

Herschman

(1993a) Macrophage nitric oxide synthase is a glucocorticoid-inhibitable primary response gene in 3T3 cells. J Cell Physiol 157: 128–132

37.

Gilbert

Herschman

(1993b) Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem Biophys Res Commun 195: 380–384

38.

Goldenberg

Rouse

(1998) Prevention of premature birth. N Engl J Med 339: 313–320

39.

Hearne

Nagey

(2000) Therapeutic agents in preterm labor: tocolytic agents. Clin Obstet Gynecol 43: 787–801

40.

Hegele-Hartung

Chwalisz

Beier

Elger

(1989) Ripening of the uterine cervix of the guinea-pig after treatment with the progesterone antagonist onapristone (ZK 98.299): an electron microscopic study. Hum Reprod 4: 369–377

41.

Iams

(1995) Current status of home uterine activity monitoring. Clin Obstet Gynecol 38: 771–779

42.

Ito

Kitamura

Mori

Hirakawa

(1979) The change in solubility of type I collagen in human uterine cervix in pregnancy at term. Biochem Med 21: 262–270

43.

Junqueira

Bignolas

Brentani

(1979) Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447–455

44.

Kitajima

Kawahara

Nakajima

Soejima

Matsuyama

Maruyama

(1994) Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem Biophys Res Commun 204: 244–251

45.

Ledingham

Denison

Kelly

Young

Norman

(1999) Nitric oxide donors stimulate prostaglandin F(2alpha) and inhibit thromboxane B(2) production in the human cervix during the first trimester of pregnancy. Mol Hum Reprod 5: 973–982

46.

Ledingham

Thomson

Young

Macara

Greer

Norman

(2000) Changes in the expression of nitric oxide synthase in the human uterine cervix during pregnancy and parturition. Mol Hum Reprod 6: 1041–1048

47.

Leppert

(1992) Cervical softening, effacement, and dilatation: a complex biochemical cascade. J Matern Fetal Med 1: 213–223

48.

Leppert

(1994) Apoptosis in the cervix of pregnant rats in association with cervical softening. Gynecol Obstet Invest 37: 150–154

49.

Murakami

Kuwata

Amakasu

Shimbara

Nakatani

Atsumi

Kudo

(1997) Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2. J Biol Chem 272: 19891–19897

50.

Nathan

(1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051–3064

51.

Nathanielsz

(1978a) Endocrine mechanisms of parturition. Annu Rev Physiol 40: 411–445

52.

Nathanielsz

(1978b) Parturition in rodents. Semin Perinatol 2: 223–234

53.

Norman

Thomson

Greer

(1998) Cervical ripening after nitric oxide. Hum Reprod 13: 251–252

54.

Puri

Garfield

(1982) Changes in hormone levels and gap junctions in the rat uterus during pregnancy and parturition. Biol Reprod 27: 967–975

55.

Radestad

Bygdeman

(1993) Are prostaglandins mediators of mifepristone (RU 486)-induced cervical softening in early pregnancy? J Lipid Mediat 6: 503–507

56.

Salvemini

Misko

Masferrer

Seibert

Currie

Needleman

(1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240–7244

57.

Salvemini

Seibert

Masferrer

Misko

Currie

Needleman

(1994) Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 93: 1940–1947

58.

Selles

Polini

Alvarez

Massheimer

(2002) Nongenomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins. Cell Signal 14: 431–436

59.

Shi

Saade

Chwalisz

Garfield

(1999) Changes in cervical resistance and collagen fluorescence during gestation in rats. J Perinat Med 27: 188–194

60.

Shi

Buhimschi

Shi

Saade

Garfield

(2000a) Genetic variability in a preeclampsia-like rat model. Am J Obstet Gynecol 182:S88

61.

Shi

Saade

Chwalisz

Garfield

(2000b) Studies of cervical ripening in pregnant rats: effects of various treatments. Mol Hum Reprod 6: 382–389

62.

Simpson

(1997) Preterm birth in the United States: current issues and future perspectives. J Perinat Neonatal Nurs 10: 11–15

63.

Srivastava

Tetsuka

Daphna-Iken

Morrison

(1994) IL–1 beta stabilizes COX II mRNA in renal mesangial cells: role of 3î-untranslated region. Am J Physiol 267: F504–F508

64.

Stys

Clewell

Meschia

(1978) Changes in cervical compliance at parturition independent of uterine activity. Am J Obstet Gynecol 130: 414–418

65.

Stys

Dresser

Otte

Clark

(1981) Effect of prostaglandin E2 on cervical compliance in pregnant ewes. Am J Obstet Gynecol 140: 415–419

66.

Swaisgood

Perkins

Garver

Zimmerman

Iams

(1997) Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice. Am J Obstet Gynecol 177: 1253–1262

67.

Sweat

Puchtler

Rosenthal

(1964) Sirius red F3ba as a stain for connective tissue. Arch Pathol 78: 69–72

68.

Szalay

Husslein

Grunberger

(1981) Collagenolytic activity of human cervical tissue, following local application of prostaglandin E2 (PG E2), using a portio adapter (author's transl). Zentralbl Gynakol 103: 1107–1112

69.

Tetsuka

Daphna-Iken

Srivastava

Baier

DuMaine

Morrison

(1994) Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 91: 12168–12172

70.

Theobald

Rath

Kuhnle

Kuhn

(1982) Histological and electron-microscopic examinations of collagenous connective tissue of the non-pregnant cervix, the pregnant cervix, and the pregnant prostaglandin-treated cervix. Arch Gynecol 231: 241–245

71.

Thomson

Lunan

Cameron

Greer

Norman

(1997) Nitric oxide donors induce ripening of the human uterine cervix: a randomized controlled trial. Br J Obstet Gynaecol 104: 1054–1057

72.

Thomson

Lunan

Ledingham

Howat

Cameron

Greer

Norman

(1998) Randomized trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy. Lancet 352: 1093–1096

73.

Thorburn

Challis

(1979) Endocrine control of parturition. Physiol Rev 59: 863–918

74.

Tornblom

Maul

Klimaviciute

Garfield

Bystrom

Malmstrom

Ekman-Ordeberg

(2005) mRNA expression and localization of bNOS, eNOS and iNOS in human cervix at preterm and term labour. Reprod Biol Endocrinol 3: 33

75.

Tschugguel

Schneeberger

Lass

Stonek

Zaghlula

Czerwenka

Schatten

(1999) Human cervical ripening is associated with an increase in cervical inducible nitric oxide synthase expression. Biol Reprod 60: 1367–1372

76.

Uldbjerg

Ekman

Malmstrom

Olsson

Ulmsten

(1983a) Ripening of the human uterine cervix related to changes in collagen, glycosaminoglycans, and collagenolytic activity. Am J Obstet Gynecol 147: 662–666

77.

Uldbjerg

Ekman

Malmstrom

Ulmsten

Wingerup

(1983b) Biochemical changes in human cervical connective tissue after local application of prostaglandin E2. Gynecol Obstet Invest 15: 291–299

78.

Uldbjerg

Ulmsten

Ekman

(1983c) The ripening ofthe human uterine cervix in terms of connective tissue biochemistry. Clin Obstet Gynecol 26: 14–26

79.

Upchurch

Ford

Weiss

Knipp

Peterson

Thompson

Eagleton

(2001) Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro. J Vasc Surg 34: 76–83

80.

Vane

Mitchell

Appleton

Tomlinson

Bishop-Bailey

Croxtall

Willoughby

(1994) Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91: 2046–2050

81.

Vidal

Mello

Pimentel

(1982) Polarization microscopy and microspectrophotometry of Sirius Red, Picrosirius and Chlorantine Fast Red aggregates and of their complexes with collagen. Histochem J 14: 857–878

82.

Watari

Fujimoto

Yamada

Nishihira

Strauss

Fujimoto

(2003) Lipopolysaccharide induces interleukin-8 production by human cervical smooth muscle cells. J Soc Gynecol Investig 10: 110–117

83.

Winkler

Fischer

Ruck

Marx

Kaiserling

Oberpichler

Tschesche

(1999) Parturition at term: parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment. Hum Reprod 14: 1096–1100

84.

Yallampalli

Buhimschi

Chwalisz

Garfield

Dong

(1996) Preterm birth in rats produced by the synergistic action of a nitric oxide inhibitor (NG-nitro-L-arginine methyl ester) and an antiprogestin (onapristone). Am J Obstet Gynecol 175: 207–212

85.

Tozzi

Babiarz

Leppert

(1995) Collagen changes in rat cervix in pregnancy-polarized light microscopic and electron microscopic studies. Proc Soc Exp Biol Med 209: 360–368

86.

Zhang

Chen

Teng

Snead

Catravas

(1998) Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells. Biochem Pharmacol 55: 1873–1880

Effects of Progesterone on iNOS,COX-2,and Collagen Expression in the Cervix

Abstract

Keywords

Materials and Methods

Animal Treatment

Tissue Preparation

Visualizing and Measuring the Changes in Rat Cervical Collagen Using the Picrosirius Polarization Method

Localization of iNOS and COX-2 in Rat Cervical Tissue Using Immunohistochemical Staining

Using Real-time RT-PCR to Characterize the iNOS and COX-2 Cervical mRNA Expression

Statistical Analysis

Results

Visualizing and Measuring the Changes in the Collagen

Localization of Cervical iNOS and COX-2 during Gestation

Cervical iNOS and COX-2 mRNA Expression during Gestation

Discussion

Footnotes

Acknowledgements

References